MedPath

Radiofrequency Ablation Versus Balloon Cryoablation in Elderly Patients With Atrial Fibrillation

Not Applicable
Conditions
Atrial Fibrillation
Interventions
Procedure: ballon cryoablation
Procedure: radiofrequency ablation
Registration Number
NCT04337567
Lead Sponsor
Vivantes Netzwerk für Gesundheit GmbH
Brief Summary

This study compares the procedural characteristics and effectivity of radiofrequency ablation and cryoablation in patients with atrial fibrillation that are 75 years or older.

Detailed Description

Radiofrequency and cryoballon ablation have been shown to be comparable to each other in terms of safety and effectivity in patients with atrial fibrillation. However, elderly patients have been underrepresented in the previous studies. The number of older patients with atrial fibrillation is high and the number of who undergo an ablation procedure for atrial fibrillation increases steadily. This prospective randomized trial compares the effectivity (recurrency of atrial arrhythmias) and periprocedural characteristics of the two established ablation methods in patients who are 75 years or older.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Patients with recurrent symptomatic paroxysmal or persistent atrial fibrillation
  • At the day of their inclusion in the study the patients have to have completed the 75th year of life
Exclusion Criteria
  • Dementia
  • Presence of left atrial thrombus
  • Left atrial volume> 50 ml/m²
  • Renal failure (GFR≤ 30 ml/min)
  • Comorbidity with an expected survival of 12 months or less.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Patients over 75 years_ballon cryoablationballon cryoablationPatients randomized to receive pulmonary vein isolation by means of ballon cryoablation.
Patients over 75 years_RF ablationradiofrequency ablationPatients randomized to receive pulmonary vein isolation by means of radiofrequency ablation.
Primary Outcome Measures
NameTimeMethod
atrial arrhythmia recurrence1 year

Number of Participants with recurrence of any atrial arrhythmia with a duration of 30 sec or longer 12 months after the ablative treatment

Secondary Outcome Measures
NameTimeMethod
procedural durationperiprocedural

Duration of the whole procedure \[min\] inclusive preparation (from entrance to the EP lab till exit from the EP lab)

contrast medium dosisperiprocedural

Amount of contrast medium used

Propofoldosisperiprocedural

Propofoldosis needed for sedation

vascular complications1 year

Number of Participants in each randomisation arm with deep vein thrombosis, peripheral embolism.

groin complicationsup to 3 months after dismission from the hospital

Number of Participants in each randomisation arm with groin complications (hematoma, av fistel, Aneuryma spurium, infection).

time to wake-up after propofol withdrawalperiprocedural

Time from withdrawal of propofole till patient awake and fully oriented (time, place, person)

Neurological complications1 year

Number of Participants in each randomisation arm with transient ischemic attack, cerebral insult, cerebral haemorrhage

duration of hospital staying [days]1 year

duration of hospital staying: from admission till discharge in days

Trial Locations

Locations (1)

Vivantes Klinikum Neukölln

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath